Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Maze Therapeutics, Inc. (MAZE) had Operating Cash Flow per Share of $27.82 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$167.50M |
|
$3.40M |
|
-- |
|
$167.50M |
|
$109.91M |
|
$57.59M |
|
$-4.18M |
|
$53.40M |
|
$53.40M |
|
$52.23M |
|
$52.23M |
|
$52.23M |
|
$52.23M |
|
$57.59M |
|
$60.88M |
|
2.40M |
|
2.73M |
|
$1.42 |
|
$1.25 |
|
| Balance Sheet Financials | |
$201.67M |
|
$6.67M |
|
$38.87M |
|
$240.54M |
|
$20.67M |
|
-- |
|
$531.05M |
|
$551.73M |
|
$-311.18M |
|
$-311.18M |
|
$-311.18M |
|
2.45M |
|
| Cash Flow Statement Financials | |
$75.95M |
|
$-1.15M |
|
$92.85M |
|
$30.25M |
|
$197.90M |
|
$167.65M |
|
$9.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
34.38% |
|
34.38% |
|
36.35% |
|
31.88% |
|
2.03% |
|
$74.81M |
|
-- |
|
-- |
|
-- |
|
0.70 |
|
-- |
|
-- |
|
-- |
|
-16.78% |
|
-16.78% |
|
21.71% |
|
-16.78% |
|
$-127.17 |
|
$27.40 |
|
|
Operating Cash Flow per Share |
$27.82 |